Early gene therapy offers hope for some patients with ALS
Published
Researchers have found that gene therapy can offer new hope to people with ALS, a serious disease that affects nerve cells and gradually makes it harder to move the body. Caroline Ingre, who works in ALS research, says: "The earlier a patient receives targeted gene therapy, the greater the chance of living longer."
Gene therapy involves trying to influence the genes that cause or contribute to the disease. The treatment is targeted, meaning it is adapted for certain types of ALS. According to Ingre, timing plays a major role. Patients who start treatment early in the course of the disease appear to have better prospects than patients who receive the treatment later.
For those living with ALS, this could be important. The disease is currently incurable, and many patients receive treatment to alleviate symptoms and improve quality of life. If more patients can receive genetic testing and treatment at an early stage, it could mean that more people get the opportunity to live longer. However, this is still a field of research, and more knowledge is needed about the long-term effects of the treatment.
In summary, the results show that early treatment may be decisive. Research continues, and future studies are expected to show how gene therapy can be used more broadly in healthcare.
Sources: www.lifesciencefocus.com
More Sweden news
- More people in Sweden use AI, most trust its answers
- SMHI issues several yellow snow warnings for parts of Sweden
- Sweden's parliament votes on a change that could revoke citizenship
- Planned data center in Skellefteå could become Sweden's largest electricity user
- Vietnam and Sweden want to develop cooperation in more areas
- Swedish gaming industry thriving this year
- Binance targeted in coup attempt: Report points to security weaknesses
- Sweden drops in climate ranking – new record low